Menu
← Oncology Approval Tracker
FDA DECISION ·
Opdivo + cisplatin + gemcitabine
nivolumab with cisplatin and gemcitabine · Bristol Myers Squibb
Open LinkedIn brief ↓1 min read · estimated
APPROVED USE
What FDA approved
First-line treatment for adults with unresectable or metastatic urothelial carcinoma with nivolumab, cisplatin and gemcitabine.
LAMPGEN ANALYSIS
Why it matters
The decision established a checkpoint inhibitor and cisplatin-based chemotherapy combination in untreated advanced urothelial disease.
What research teams should watch
Document baseline cisplatin fitness and track where chemotherapy ends and nivolumab maintenance begins.
PRIMARY RECORDS